Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 30

1.

Respiratory medications and the risk of cardiac arrhythmias.

Huerta C, Lanes SF, García Rodríguez LA.

Epidemiology. 2005 May;16(3):360-6.

PMID:
15824553
2.

[Asthma in the elderly].

Radenne F, Verkindre C, Tonnel AB.

Rev Mal Respir. 2003 Feb;20(1 Pt 1):95-103. Review. French.

PMID:
12709638
3.
4.
5.

[Anti-obstructive anti-inflammatory therapy: no problems in pneumology, problematic in cardiology?].

Hauck RW, Virchow JC.

Med Klin (Munich). 2002 Jun 15;97(6):350-6. Review. German.

PMID:
12136470
7.
8.

Inhaled corticosteroids for stable chronic obstructive pulmonary disease.

Yang IA, Clarke MS, Sim EH, Fong KM.

Cochrane Database Syst Rev. 2012 Jul 11;(7):CD002991. doi: 10.1002/14651858.CD002991.pub3. Review.

PMID:
22786484
9.

[Evaluation of hyperkinetic cardiac arrhythmia in chronic obstructive bronchopneumopathy].

Conte G, Lauro S, Lazzarin M, Rigon N, Perrone A.

Minerva Cardioangiol. 1997 Sep;45(9):429-33. Review. Italian.

PMID:
9446064
10.

[Secondary osteoporosis: Inhaled corticosteroids induced osteoporosis in respiratory diseases].

Ieda Y, Nagasaka Y.

Clin Calcium. 2007 Jun;17(6):955-62. Review. Japanese.

PMID:
17548937
11.

Inhaled corticosteroids for stable chronic obstructive pulmonary disease.

Yang IA, Fong KM, Sim EH, Black PN, Lasserson TJ.

Cochrane Database Syst Rev. 2007 Apr 18;(2):CD002991. Review. Update in: Cochrane Database Syst Rev. 2012;7:CD002991.

PMID:
17443520
12.

[Asthma and COPD: guidance in the jungle of inhalative drugs].

Hering T.

MMW Fortschr Med. 2015 May 28;157(10):59, 61-2. doi: 10.1007/s15006-015-3139-6. Review. German. No abstract available.

PMID:
26019099
13.

Drugs for chronic obstructive pulmonary disease.

[No authors listed]

Treat Guidel Med Lett. 2010 Nov;8(99):83-8; quiz 89-90. Review. No abstract available.

PMID:
21045755
14.

Inhaler devices for the treatment of asthma and chronic obstructive airways disease (COPD).

Wright J, Brocklebank D, Ram F.

Qual Saf Health Care. 2002 Dec;11(4):376-82. Review.

15.

Safety of inhaled budesonide: clinical manifestations of systemic corticosteroid-related adverse effects.

Christensson C, Thorén A, Lindberg B.

Drug Saf. 2008;31(11):965-88. Review.

PMID:
18840017
16.

Combined corticosteroid and long-acting beta(2)-agonist in one inhaler versus inhaled corticosteroids alone for chronic obstructive pulmonary disease.

Nannini LJ, Poole P, Milan SJ, Kesterton A.

Cochrane Database Syst Rev. 2013 Aug 30;(8):CD006826. doi: 10.1002/14651858.CD006826.pub2. Review.

PMID:
23990350
17.

Inhaled steroids and risk of pneumonia for chronic obstructive pulmonary disease.

Kew KM, Seniukovich A.

Cochrane Database Syst Rev. 2014 Mar 10;(3):CD010115. doi: 10.1002/14651858.CD010115.pub2. Review.

PMID:
24615270
18.

Long-acting beta2-agonists versus anti-leukotrienes as add-on therapy to inhaled corticosteroids for chronic asthma.

Ram FS, Cates CJ, Ducharme FM.

Cochrane Database Syst Rev. 2005 Jan 25;(1):CD003137. Review. Update in: Cochrane Database Syst Rev. 2006;(4):CD003137.

PMID:
15674901
19.

Long-acting beta2-agonists versus anti-leukotrienes as add-on therapy to inhaled corticosteroids for chronic asthma.

Ducharme FM, Lasserson TJ, Cates CJ.

Cochrane Database Syst Rev. 2006 Oct 18;(4):CD003137. Review. Update in: Cochrane Database Syst Rev. 2011;(5):CD003137.

PMID:
17054161
20.

Addition of long-acting beta2-agonists to inhaled corticosteroids for chronic asthma in children.

Chauhan BF, Chartrand C, Ni Chroinin M, Milan SJ, Ducharme FM.

Cochrane Database Syst Rev. 2015 Nov 24;(11):CD007949. doi: 10.1002/14651858.CD007949.pub2. Review.

PMID:
26594816

Supplemental Content

Support Center